Invenomic Capital Management LP

Item 5: Fees and Compensation
Invenomic receives an asset-based management fee and is eligible to receive a performance allocation
or fee for the private funds.

Invenomic deducts its management fees (“Management Fee”) generally from the private funds
monthly in arrears in such amounts as set forth in the Governing Documents of such private fund.
Invenomic Private Fund GP LLC, an affiliate of and wholly owned by Invenomic, is a Delaware
limited liability company that serves as the general partner or managing member to one or more of the
private funds (the “General Partner”), is eligible to receive performance-based allocations
(“Performance Allocation”) in respect of each private fund on an annual basis in arrears and upon
withdrawals or redemptions by Investors, subject to a “high-water mark”. For a further discussion of
the Performance Allocation and the “high-water mark”, please see Item 6.

Invenomic also receives an asset-based management fee and is eligible to receive a performance
allocation or fee for the UCITS fund. The Management Fee will accrue daily and will be payable
monthly in arrears on the last dealing day for the month. The amounts of the Management Fee are set
forth in the Governing Documents of the UCITS fund.

The Performance Allocation with respect to the UCITS fund will be calculated in respect of each
calendar year. The calculation is based on the share class owned in the UCITS fund. The Performance
Allocation, if any, will be deemed to be accrued on a daily basis. For further discussion on the
Performance Allocation for the UCITS fund, please see Item 6.

Invenomic will, from time to time and in its sole discretion, waive, reduce or rebate the Management
Fee and/or Performance Allocation with respect to the investment of any Investor, including its
employees, owners and/or affiliates. In the event a Client terminates its investment management
agreement with Invenomic, appropriate treatment will be given to all Management Fees and other
compensation collected in advance (e.g., the Management Fee would be pro-rated based upon the
number of days elapsed in the applicable period prior to termination and the balance of the
Management Fee collected would be refunded).

In addition to the Management Fee and Performance Allocation, and as set forth in more detail in the
applicable Governing Documents, the Funds will pay all costs and expenses related to its investments
and its operations permissible under applicable law. Expenses are generally shared [pro rata] by all of
the Investors in a Fund, while expenses related to one or more particular series or classes of
investments may be allocated to such series or classes or shared [pro rata] by the Investors in such
series or class. In the event that one or more Funds invest all or a substantial portion of its assets
through a “master fund,” each such “feeder fund” will also be responsible for its pro rata portion of
such master fund’s costs and expenses. Expenses of more than one Fund will be shared on an equitable
basis among such Funds. Notwithstanding the foregoing, Invenomic may elect to bear some or all of
the above expenses of the Clients.

Invenomic and its supervised persons do not accept any compensation from third parties (e.g.,
brokerage commissions) for the sale of securities or other investment products, including interests in
the Funds.

For more information regarding Invenomic’s brokerage practices and expenses, please see Item 12.

Item 7: Types of Clients
Invenomic provides investment advisory services to the Funds. Investors in the private funds include,
but are not limited to, high net worth individuals, family offices, endowments, foundations, trusts,
charitable organizations, pension plans, and corporate or business entities.

Details concerning applicable investor suitability criteria for the private funds are set forth in the
Governing Documents. The minimum commitment for an Investor is outlined in the applicable private
fund’s Governing Documents, including the discretion of Invenomic and its affiliates to accept less
than the minimum investment threshold. Each Investor in the private funds is required to meet certain
suitability qualifications.

The minimum investment amount for each share class in the UCITS fund is set out in the fund’s
Governing Documents.